Finerenone for CKD in type 2 diabetes (Nice, March 2023)

6th April 2023 by Dr Louise Hudman

Finerenone for CKD in type 2 diabetes (Nice, March 2023)

This is a new guideline from Nice advising that we can use finerenone for selected patients with CKD and type 2 diabetes.

What is finerenone?

It is a non-steroidal mineralocorticoid receptor antagonist. According to the BNF it “inhibits receptor-mediated sodium reabsorption and decreases receptor overactivation, thereby reducing the inflammation and fibrosis that lead to kidney damage”.

Why is CKD such an issue for people with T2DM?

This is summarised from what Nice has put in their guideline.

Read more

No credit card details needed – it takes two minutes.

Join free trial


Already a member? Login to view this content.


Related content

"I was introduced to the local locum chambers several months ago when I made a career move from partnership. I now combine salaried and locum roles. The chambers provides helpful support, leadership, advice and governance and reduces professional isolation. This combination of support reassures me and helps me provide safe and consistent care to patients within the community . There is a useful, innovative online portal - LocumDeck - which helps me access local work and which has efficient systems for reconciliation of finance including pensions. I would highly recommend joining a locum chambers for any GPs starting out in the locum world ."

Dr Adrian Richardson, GP

Dr Adrian Richardson, GP

See the full list of features within our NASGP membership plans